Search

Nikki A Delk

from Richardson, TX
Age ~50
Get Report
Also known as:
Nikki Ayanna Delk, Nikki A Gelk
Connected to:
Alvin L Delk, 85Bobbie A Delk, 47Brittany N Delk, 34Chasity L Delk, 34Dianne G Delk, 70Elizabeth A Delk, 37Greg W Delk, 55Karen A Delk, 56Laurie E Delk, 48Lynn Delk, 60

Nikki Delk Phones & Addresses

  • Richardson, TX
  • 7550 Kirby Dr, Houston, TX 77030 (713) 592-0981
  • 7550 Kirby Dr APT 232, Houston, TX 77030
  • 1341 Castle Ct, Houston, TX 77006 (713) 523-0367
  • Washington, DC
  • Fort Walton Beach, FL
  • San Antonio, TX
  • Chesapeake, VA

Work

Position: Clerical/White Collar

Education

Degree: Graduate or professional degree

Resumes

Resumes

Nikki Delk Photo 1

Faculty Fellow (Research Assistant Professor)

View page
Position:
Faculty Fellow (Research Assistant Professor) at Rice University
Location:
Houston, Texas Area
Industry:
Research
Work:
Rice - Rice University since Apr 2009
Faculty Fellow
Education:
Georgetown University
Bachelor of Science (B.S.), Mathematics Rice University
Doctor of Philosophy (Ph.D.), Molecular Biology
Nikki Delk Photo 2

Nikki Delk

View page

Publications

Us Patents

Low Molecular Weight Cyclin E (Lmw-E) As A Biomarker For Personalization Of Cancer Therapies

View page
US Patent:
20120114636, May 10, 2012
Filed:
Mar 10, 2010
Appl. No.:
13/255380
Inventors:
Khandan Keyomarsi - Houston TX, US
Nikki Delk - Houston TX, US
Kelly K. Hunt - Houston TX, US
Hannah Wingate - Humble TX, US
Elizabeth A. Mittendorf - Houston TX, US
Assignee:
The Board of Regents of the University of Texas System - Austin TX
Research Development Foundation - Carson City NV
International Classification:
A61K 39/395
A61P 35/00
A61K 31/566
A61K 31/553
G01N 33/577
A61K 31/4196
US Classification:
4241331, 435 723, 514383, 514177, 51421108
Abstract:
Methods are disclosed for predicting a patient response to anti-Her2 therapy or anti-aromatase therapy. In certain embodiments, the methods involve the identification of low molecular weight cyclin E (LMW-E) in cancers, such as breast cancer cells, as a predictive and prognostic marker. In further embodiments, LMW-E expression by a cancerous or pre-cancerous cell may be used to predict response to an aromatase inhibitor and/or CDK2 inhibitor, and determination of LMW-E expression may be used in the personalization of cancer therapies.
Control profile
Nikki A Delk from Richardson, TX, age ~50 Get Report